Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000760916 | SCV000890812 | pathogenic | not provided | 2018-12-24 | criteria provided, single submitter | clinical testing | The Q315X variant in the KIAA0753 gene has been reported previously in the compound heterozygous state with another KIAA0753 variant in a fetus with short-rib thoracic dysplasia (Hammarsjo et al., 2017). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. unction either through protein truncation or nonsense-mediated mRNA decay. The Q315X variant is observed in 6/126332 (0.0047%) alleles from individuals of European (non-Finnish) background in large population cohorts, and no individuals were reported to be homozygous (Lek et al., 2016). We interpret Q315X as a pathogenic variant. |
Rare Disease Group, |
RCV000590971 | SCV000580666 | pathogenic | Jeune thoracic dystrophy; Familial aplasia of the vermis | 2017-06-21 | no assertion criteria provided | research | |
OMIM | RCV001559336 | SCV001781545 | pathogenic | Short-rib thoracic dysplasia 21 without polydactyly | 2021-10-07 | no assertion criteria provided | literature only |